Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Tax Rate (2016 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Tax Rate for 10 consecutive years, with 3.96% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate rose 7942.0% year-over-year to 3.96%, compared with a TTM value of 3.98% through Dec 2025, up 2103.0%, and an annual FY2025 reading of 3.98%, up 2103.0% over the prior year.
  • Tax Rate was 3.96% for Q4 2025 at Zevra Therapeutics, down from 44.32% in the prior quarter.
  • Across five years, Tax Rate topped out at 44.32% in Q3 2025 and bottomed at 75.47% in Q4 2024.
  • Average Tax Rate over 5 years is 5.46%, with a median of 0.42% recorded in 2024.
  • Peak annual rise in Tax Rate hit 7942bps in 2025, while the deepest fall reached -6208bps in 2025.
  • Year by year, Tax Rate stood at 1.27% in 2021, then skyrocketed by 59bps to 0.53% in 2022, then crashed by -143bps to 1.28% in 2023, then plummeted by -5813bps to 75.47% in 2024, then skyrocketed by 105bps to 3.96% in 2025.
  • Business Quant data shows Tax Rate for ZVRA at 3.96% in Q4 2025, 44.32% in Q3 2025, and 2.86% in Q2 2025.